Global Cellulite Treatment Market 2024 : Trends, Business Growth And Major Driving Factors | Hologic Inc., Merz Pharma GmbH & Co. KGaA, Lumenis Ltd, Cynosure Inc

"The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Cellulite Treatment Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The cellulite treatment market size has grown rapidly in recent years. It will grow from $2.01 billion in 2023 to $2.25 billion in 2024 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to beauty and aesthetic concerns, increasing disposable income, media influence and advertising, aging population, growing fitness and wellness culture.

The cellulite treatment market size is expected to see rapid growth in the next few years. It will grow to $3.35 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to advancements in non-invasive treatments, rising demand for minimally invasive procedures, personalized and combination therapies, global increase in cosmetic procedures, influence of wellness tourism. Major trends in the forecast period include focus on long-term results, telemedicine consultations for treatment planning, social media influencer partnerships, at-home cellulite treatment devices, educational campaigns on realistic expectations.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12011&type=smp

Market Segmentation:
The cellulite treatment market covered in this report is segmented -

1) By Procedure: Non-Invasive, Minimally Invasive, Topical
2) By Cellulite Type: Soft, Hard, Edematous
3) By End User: Hospitals, Cosmetic Surgery Centers, Specialized Dermatology Clinics

Major Driver - Global Surge In Obesity Catalyzing Growth In The Cellulite Treatment Market
Increasing obesity cases are expected to propel the growth of the cellulite treatment market forward. Obesity is a medical condition characterized by an excessive accumulation of body fat to the extent that it may harm an individual's health. Increased obesity and prolonged fat accumulation stimulate the formation of more cellulite as the fat puts stress on lymphatic vessels that may lead to tissue breakdown and, eventually, cellulitis. For instance, in March 2022, according to the World Obesity Atlas 2022 report, the estimated global number of people with obesity (Class I, II, and III) =30kg/m2 in 2020 was 764 million, expected to increase to 892 million by 2025. Thus, the increasing obesity cases are propelling the cellulite treatment market.

Competitive Landscape:
Major companies operating in the cellulite treatment market report are Hologic Inc., Merz Pharma GmbH & Co. KGaA, Lumenis Ltd, Cynosure Inc., ZELTIQ Aesthetics, BTL Industries Inc., Cutera Inc., Cytek Biosciences, Candela Corporation, Zimmer Aesthetics, Venus Concept, Solta Medical, LPG Systems, Fotona d.o.o., Viora Ltd., SharpLight Technologies Inc., Alma Lasers Ltd., Beijing Nubway S&T Co Ltd, Ellipse A/S, Lynton Lasers Ltd., EndyMed Medical Ltd., VIP Italia, Cellfina, Pollogen Ltd, Endo Systems LLC, Cosmetic Laser Solutions MedSpa, LipoTherapeia, Tanceuticals LLC, Synergy MedAesthetics, Asclepion Laser Technologies GmbH

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/cellulite-treatment-global-market-report

Top Trend - Transformative Products Redefining The Cellulite Treatment Market
Product innovation is a key trend gaining popularity in the cellulite treatment market. Major companies in the cellulite treatment market are introducing innovative products to sustain their position in the market. For instance, in March 2022, Endo International plc, an Ireland-based pharmaceuticals company, launched Qwo (collagenase clostridium histolyticum-aaes) injectable for treating cellulite. It is the first and only FDA-approved injectable treatment for moderate to severe cellulite treatment. QWO is hypothesized to release the fibrous septae enzymatically by mainly targeting Types 1 and 3 collagen when injected into the treatment area, which may result in skin smoothing and an improved look of cellulite.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Cellulite Treatment Market Characteristics
3. Cellulite Treatment Market Trends And Strategies
4. Cellulite Treatment Market - Macro Economic Scenario
5. Cellulite Treatment Market Size And Growth
…..
27. Cellulite Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.